Open-Label, Randomized, 3-Way Crossover Study To Estimate The Interaction Between Multiple Dose Rifabutin And Lersivirine (UK-453,061) In Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 29 May 2012
At a glance
- Drugs Lersivirine (Primary) ; Rifabutin (Primary)
- Indications HIV infections; Mycobacterium avium complex infections
- Focus Pharmacokinetics
- 29 May 2012 Results published in Antimicrobial Agents and Chemotherapy.
- 07 Sep 2010 Actual end date added to 1 Aug 2010 as reported by ClinicalTrials.gov.
- 07 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.